If it's true that the early bird gets the worm, then the latecomers need to have some special tactics to ensure they don't go hungry. In the vaginal yeast infection treatment category, the early birds, Ortho Pharmaceutical's Monistat 7 and Gyne-Lotrimin from Schering-Plough Healthcare, literally flew off the shelves and amassed huge market shares when the active ingredients in their products went over-the-counter about three years ago. The market innovators, Monistat 7 and Gyne-Lotrimin, ...

REGISTER TO VIEW THIS ARTICLE - Register for a Free Account

Why Register for FREE?

Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick.  What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
 

Click here to read the FAQ page if you have any questions (opens in a new window)
 

Attention Paid Print Subscribers:  While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.

Already registered? here.